Immune Checkpoint Inhibitor-Induced Lymphocytic Esophagitis

Immune checkpoint inhibitors (ICIs) have emerged as effective treatments for a wide variety of advanced malignancies. However, their use is associated with numerous immune-related toxicities, including within the gastrointestinal tract. We present a rare case of checkpoint inhibitor-induced lymphocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Shefali, Munankami, Salina, Desai, Parth, Altomare, John, Shah, Nirav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317789/
https://www.ncbi.nlm.nih.gov/pubmed/37409215
http://dx.doi.org/10.7759/cureus.39920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317789/
https://www.ncbi.nlm.nih.gov/pubmed/37409215
http://dx.doi.org/10.7759/cureus.39920

Ejemplares similares